We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
34.50 | 2.06% | 1,707.50 | 1,706.50 | 1,707.50 | 1,712.50 | 1,673.00 | 1,685.50 | 2,048,203 | 12:09:32 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 14.22 | 70.09B |
Date | Subject | Author | Discuss |
---|---|---|---|
08/2/2017 12:24 | Core all looks strong to me: Core results 2016 Growth Q4 2016 Growth ------------ ------------ GBPm .....CER% .....GBP%..... GBPm .....CER% .....GBP% ------- ----- ----- -------- ----- ----- Turnover 27,889 .....6 .....17 .....7,586 .....3 .....21 Core operating profit 7,771..... 14..... 36 .....2,062..... 16 .....52 Core earnings per share 102.4p .....12 .....35 .....26.1p..... 11..... 45 | tradermichael | |
08/2/2017 12:24 | 15.18. at 12.1919, hopefully a good omen ). | essentialinvestor | |
08/2/2017 12:22 | Added some more, nice 23p divi in just a couple of weeks. | woodhawk | |
08/2/2017 12:20 | Added back 40% of what I sold. | essentialinvestor | |
08/2/2017 12:18 | Focus on CER - okish to me. An extra £2bn pumped into intangibles - what is that - future amortisation costs. | alphorn | |
08/2/2017 12:14 | But the share price down 2.7%.Does not make any sense,but there you go,thats the market for you.Will probably finish up on the day,by the close hopefully.Just bounced off 1516 | garycook | |
08/2/2017 12:13 | It had spiked up initially then crashed down the same amount when I made my comment.Since then it has continued falling. As you point out the market has now made its mind up. It didn't like it. | adh0 | |
08/2/2017 12:13 | Not to me tbh, CORE EPS outlook for '17 looked on the lower side, but that is just a quick read through, sold a few on the mini bounce. As mentioned earlier AZN on resultswas pushed lower, then bounced back quickly. | essentialinvestor | |
08/2/2017 12:12 | Sp Cant seem to make up it s mind ??It down 2.6% Clearly market dint like it . | robrah | |
08/2/2017 12:11 | Looks fine to me also. | spcecks | |
08/2/2017 12:08 | All looks fine to me. Not exceptional but certainly as expected. Dividend outlook maintained which in itself is now almost 5%. Everything that should be up was up. The share price can't seem to make its mind up at the moment though. | adh0 | |
08/2/2017 10:56 | Resistance levels 1596p & 1715p. Support 1510p | ny boy | |
08/2/2017 08:51 | With AZN we saw a plunge lower then a sharp recovery, may be a very different reaction with GSK, but just thought I would mention. | essentialinvestor | |
08/2/2017 08:49 | lol I would hope their clinical trial data is a little more accurate! ). | essentialinvestor | |
08/2/2017 08:18 | Yes, results at 12.00 noon, webcast at 14.30pm (Note, the website says 12.00 BST, - could be an error as they also say 07:00 EST (which is currently 5h difference), so going for 12.00 GMT) | tradermichael | |
08/2/2017 08:03 | What time are the Results 12 Noon ? | garycook | |
08/2/2017 07:59 | GSK shares have climbed nearly 11 percent over the past year, as compared with a more than 23-percent rise in the Footsie. Today's results are expected to show 11-12% growth. When will this be mirrored to the market, with a significant upward rating of the share price? | tradermichael | |
07/2/2017 21:58 | LOL - what a ridiculous headline - the chart they print shows prices recovered almost immediately (from a drop of less than 1%) and ended up a piffling 0.36% down. Clearly no one takes that buffoon seriously. The sooner they impeach the moron the better. | woodhawk | |
07/2/2017 20:46 | Trump Sinks Drug Stocks Again on Medicare Drug Price Negotiation | philanderer | |
07/2/2017 09:21 | Hopefully. | essentialinvestor | |
07/2/2017 09:16 | Looks like a big day tomorrow and doubt that AW will want to bow out under a cloud. Good numbers could establish a longer term trend here. | ygor706 | |
06/2/2017 15:07 | Looking forward to the nos on Wednesday | ny boy | |
05/2/2017 21:19 | GSK gets a buy rec in the Sunday Times Business section. | joshgroeny | |
03/2/2017 08:23 | GSK is scheduled to report fourth-quarter 2016 and full-year results on 8th Feb. Last quarter, the company delivered a positive earnings surprise of 7.79%. | tradermichael |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions